EASL-CLIF标准在慢加急性肝衰竭诊断与预后上优于NACSELD标准
该研究基于UNOS 2016至2020年数据,比较EASL-CLIF与NACSELD标准诊断ACLF的患病率和30天死亡率。结果显示EASL-CLIF检出更多ACLF患者且预后区分能力更强,两标准间存在明显不一致。
要点
- EASL-CLIF标准诊断ACLF的敏感性高于NACSELD标准。
- EASL-CLIF分级与30天全因死亡率呈梯度相关。
- NACSELD无器官衰竭者经EASL-CLIF分层后死亡率差异显著。
核心结论
- EASL-CLIF与NACSELD标准诊断的ACLF患病率和30天死亡率存在明显不一致。
- EASL-CLIF标准对ACLF的检出敏感性更高,预后判断能力更好。
研究设计与样本
- 基于UNOS 2016年1月11日至2020年8月31日数据的比较分析。
主要发现
- 10,198例(21%)成人患者为EASL-CLIF ACLF 1-3级,其中仅15.3%符合NACSELD-ACLF。
- EASL-CLIF 3级患者中仅48.8%为NACSELD-ACLF,16.8%无器官衰竭,34.4%有1个器官衰竭。
- EASL-CLIF 0-3级的30天全因死亡率分别为1.5%、7.7%、13.3%和25.8%。
- 无NACSELD-ACLF与有NACSELD-ACLF者的30天全因死亡率分别为15.4%和28.1%。
- NACSELD无器官衰竭者按EASL-CLIF 0-3级分层,30天无移植死亡率分别为1.5%、10.5%、43.5%和86%。
临床怎么用
- 临床诊断ACLF和评估短期预后时,EASL-CLIF标准可能更敏感且预后区分更细。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: There is no consensus on the best definition for acute-on-chronic liver failure (ACLF). In this study, we compared the prevalence and 30-day all-cause and transplant-free mortality of patients with ACLF identified by European Association for the Study of the Liver-Chronic Liver Failure Consortium (EASL-CLIF) and North American Consortium for the Study of End-stage Liver Disease (NACSELD) criteria. METHODS: We performed this comparative analysis using the United Network for Organ Sharing (UNOS) data from January 11, 2016 to August 31, 2020. RESULTS: A total of 10,198 (21%) adult patients had EASL-CLIF ACLF grade 1-3, but of these only 15.3% had ACLF by NACSELD. Of the 2,562 with EASL-CLIF ACLF grade 3, only 48.8% had NACSELD-ACLF, 16.8% had no organ failure (OF) and 34.4% had 1 OF. The 30-day all-cause mortality was 1.5%, 7.7%, 13.3% and 25.8% for EASL-CLIF grade 0-3, respectively, and it was 15.4% and 28.1% in those without and with NACSELD-ACLF. When EASL-CLIF grade 3 patients were stratified by NACSELD OF, the mortality ranged from 18.6% with no OF to 41.0% with 4 OFs. The 30-day transplant-free mortality in those with no OF by NACSELD was 2.7%, but when the same group is stratified by EASL-CLIF grades 0-3, the mortality rates were 1.5%, 10.5%, 43.5% and 86%, respectively; the mortality rates ranged from 3.0% to 75.7% in those with 1 OF by NACSELD. CONCLUSIONS: There is a clear discordance in the prevalence and 30-day mortality rates of patients with ACLF identified by the EASL-CLIF and NACSELD criteria. EASL-CLIF criteria have a better sensitivity to detect ACLF and have a better prognostic capability. LAY SUMMARY: There is no consensus on the definition of acute-on-chronic liver failure. European (EASL-CLIF) and North American (NACSELD) consortia have each proposed a commonly used definition. In this study, we compared the prevalence and short-term (30-day) mortality based on these definitions. Using a very large data set, we observed that there was a significant discordance in the prevalence and mortality based on these criteria. EASL-CLIF criteria appeared to be more sensitive to identify acute-on-chronic liver failure, and were better at predicting all-cause and short-term mortality.
引用
- Li F, Thuluvath PJ. EASL-CLIF criteria outperform NACSELD criteria for diagnosis and prognostication in ACLF. J Hepatol. 2021. PMID: 34102198. doi:10.1016/j.jhep.2021.05.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。